6122
J. Am. Chem. Soc. 2000, 122, 6122-6123
Identification of Active Site Cysteine Residues that
Function as General Bases: Diaminopimelate
Epimerase
†
‡
‡
Carolyn W. Koo, Andrew Sutherland, John C. Vederas, and
John S. Blanchard*,†
Department of Biochemistry
Albert Einstein College of Medicine
Bronx, New York 10461
Figure 1. Reaction catalyzed by diaminopimelate epimerase.
Department of Chemistry, UniVersity of Alberta
Edmonton, Alberta, Canada T6G 2G2
ReceiVed April 5, 2000
D,L-meso-Diaminopimelate (DAP), a precursor to L-lysine in
bacterial lysine biosynthesis, is a diamino acid which is incor-
porated into the pentapeptide of the Gram-negative peptidoglycan
1
moiety. Diaminopimelate epimerase (EC 5.1.1.7), a member of
the pyridoxal phosphate-independent amino acid racemases,
catalyzes the interconversion of L,L and D,L-meso-diaminopimelate
2
(
Figure 1). Mechanistically similar to the well-studied PLP-
3
independent amino acid racemases, especially proline racemase
and glutamate racemase,4,5 DAP epimerase uses two cysteine
residues. The thiolate form of one of the cysteines functions as
the general base, and the other cysteine thiol functions as the
general acid in one direction, while these ionization states, and
functions, must be necessarily reversed for the other direction.
An early mechanistic study of the Escherichia coli diaminopime-
Figure 2. Proposed mechanism of hydrogen fluoride elimination by DAP
epimerase. The product after HF elimination of L,L- and D,L-3-fluoro-
DAP (1 and 2) forms the enamine (3), which spontaneously hydrolyzes
and cyclizes to generate tetrahydrodipicolinic acid (4).
2
late epimerase supported a two-base mechanism. The irreversible
inhibition of the E. coli enzyme due to the alkylation of Cys73
by an active site-directed inhibitor, 2-(4-amino-4-carboxybutyl)-
aziridine-2-carboxylate (aziDAP), suggested that this cysteine
values of 4 µM and 25 µM, respectively), the enzyme was also
found to rapidly eliminate hydrogen fluoride (HF) from 2,
epimerize 1, and slowly eliminate HF from 1. The product formed
from this elimination is the enamine (3), which spontaneously
cyclizes (possibly via hydrolysis to the intermediate 2-keto-6-
aminopimelate) to tetrahydrodipicolinic acid (4, Figure 2).
Monitoring hydrogen fluoride release by 19F NMR, both elimina-
tion and epimerization products were identified with wild-type
H. influenzae DAP epimerase (data not shown). Single mutants,
C73A, C73S, C217A, and C217S, and the double mutant, C73S/
C217S, were prepared and purified from E. coli.10 Each mutant
was incubated with 1 and 2 and monitored continuously for HF
elimination (Table 1).
6
residue is present at or near the active site. The three-dimensional
structure of the Haemophilus influenzae diaminopimelate epime-
rase has been determined, and the 274-amino acid monomeric
enzyme has the two conserved cysteine residues, Cys73 and
Cys217, in disulfide linkage at the interface of two structurally
7
superimposable domains. Kinetic and isotopic studies of the
reduced, active enzyme suggest these two cysteine residues are
8
the catalytic acid and base. The assignment of the two active-
site cysteines responsible for proton abstraction in the L,L f D,L
and D,L f L,L directions has been investigated using diasteriomeric
3
-fluoro-DAP substrates and cysteine site-directed mutants of H.
Although the single mutants of diaminopimelate epimerase,
C73A and C217A, were found to be inactive as epimerases, these
enzymes were able to catalyze the elimination of hydrogen
fluoride via abstraction of the C-2 hydrogen. The C73A mutant
was able to rapidly catalyze elimination of the D,L-3-fluoro-DAP
analogue (2) and was essentially unable to catalyze elimination
with the L,L-3-fluoro-DAP analogue (1, Figure 3a and 3b). This
trend was reversed with the C217A mutant, which catalyzed HF
elimination from L,L-3-fluoro-DAP but was incapable of cata-
lyzing HF elimination from D,L-3-fluoro-DAP (Figure 3c and 3d).
The single mutants, C73S and C217S were able to catalyze both
epimerization of DAP and HF elimination of the fluoro-DAP
analogues (Table 1). Qualitatively, the C73S mutant was able to
influenzae diaminopimelate epimerase.
The 3-fluoro analogue of L,L-DAP, (2S,3R,6S)-3-fluoro-2,6-
diaminopimelic acid (1) and the 3-fluoro analogue of D,L-DAP,
the 2R,3S,6S isomer (2), were synthesized and tested with the E.
coli DAP epimerase.9 Although 1 and 2 were competitive
inhibitors of wild-type E. coli DAP epimerase, (exhibiting K
i
*
To whom correspondence may be addressed. Telephone: (718) 430-
3
096. Fax: (718) 430-8565. E-mail: blanchar@aecom.yu.edu.
†
‡
Albert Einstein College of Medicine.
University of Alberta.
(
1) (a) Scapin, G.; Blanchard, J. S. AdV. Enzymol. 1998, 72, 279-324. (b)
Cox, R. J. Nat. Prod. Rep. 1996, 13, 29-43. (c) Cox, R. J.; Sutherland, A.;
Vederas, J. C. Bioorg. Med. Chem. 2000, in press.
(
(
2) Wiseman, J. S.; Nichols, J. S. J. Biol. Chem. 1984, 259, 8907-8914.
3) (a) Rudnick, G.; Abeles, R. H. Biochemistry 1975, 14, 4515-4522.
(
b) Belasco, J. G.; Albery, W. J.; Knowles, J. R. Biochemistry 1986, 25, 2552-
(9) (a) Gelb, M. H.; Lin, Y.; Pickard, M. A.; Song, Y.; Vederas, J. C. J.
Am. Chem. Soc. 1990, 112, 4932-4942. (b) Sutherland, A.; Vederas, J. C. J.
Chem. Soc., Chem. Commun. 1999, 1739-1740.
2
3
3
558.
(
4) Gallo, K. A.; Tanner, M. E.; Knowles, J. R. Biochemistry 1993, 32,
991-3997.
(10) Mutations at the Cys73 and Cys217 positions of the H. influenzae
diaminopimelate epimerase (dapF gene) were introduced by PCR (Perkin-
Elmer). Sequencing of each of the plasmid DNA confirmed successful
mutation(s) of the enzyme. Expression and purification of the mutant enzymes
(
5) Tanner, M. E.; Gallo, K. A.; Knowles, J. R. Biochemistry 1993, 32,
998-4006.
(
6) (a) Higgins, W.; Tardif, C.; Richaud, C.; Krivanek, M. A.; Cardin, A.
8
Eur. J. Biochem. 1989, 186, 137-143. (b) Gerhart, F.; Higgins, W.; Tardif,
were accomplished following the protocol for the wild-type enzyme.
C.; Ducep, J.-B. J. Med. Chem. 1990, 33, 2157-2162.
Electrospray ionization mass spectrometry confirmed the mass of the mutant
epimerases as well as the purity of the samples. Further details of the cloning,
expression, and purification of the mutant enzymes will be published
separately.
(
7) Cirilli, M.; Zheng, R.; Scapin, G.; Blanchard, J. S. Biochemistry 1998,
3
7, 16452-16458.
(
8) Koo, C. W.; Blanchard, J. S. Biochemistry 1999, 38, 4416-4422.
1
0.1021/ja001193t CCC: $19.00 © 2000 American Chemical Society
Published on Web 06/08/2000